The COVID-19 pandemic has proven that research can be done more efficiently. To make these efficiencies sustainable, the sites’ perspective must be considered. Sponsors, CROs, and sites should engage early in the process to understand what is feasible–what works well and what must be fixed–to improve the way we develop new therapies and interventions that advance human health.

To discuss burning topics like these, Advarra presents Fireside Chats—a series of video conversations between research community leaders.

In this conversation, Gadi Saarony, CEO of Advarra, speaks with Deb Tatton, Senior Vice President, Global Clinical Operations at Parexel. Gadi and Deb talk about the challenges sites face, bring awareness to these issues, and propose possible ways sponsors and CROs can work more collaboratively with sites to improve study startup and address the changing clinical trial landscape.

• Define the research challenges sites face, including pressure to quickly adapt site practices and meet expectations of the “new normal”
• Describe the enhanced role of technology (site and sponsor/CRO) in the future of clinical trials
• Outline questions sponsors and CROs can ask sites—and sites can ask sponsors and CROs—to help ensure clinical development plans are feasible and appropriate

• Presenters
• Certificate of Attendance

Gadi Saarony

MBA

CEO, Advarra

Deb Tatton

Senior Vice President, Global Clinical Operations, Parexel

There is no longer a survey component to the webinar. After watching this webinar in its entirety, you will receive a certificate of attendance. This certificate will be emailed to you within one business day of watching the webinar.

Please note that if your organization has other staff members who wish to get a certificate of attendance, each person must register and watch the webinar in its entirety. Visit our Webinar Help page for more information on certificates of attendance.